Their son Owen, born six weeks early in November 2015, developed necrotizing enterocolitis a few days after birth. The ...

Recent NEC lawsuits have shaken the infant formula industry, raising concerns over the future of preterm formula availability ...

The company primarily focuses on its drug candidate, IBP-9414, that is designed to reduce the incidence of necrotizing enterocolitis (NEC) and improve sustained feeding tolerance (SFT) in prematurely ...